<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="Of all three, COVID-19 appears to have the highest secondary" exact="infection" post="rate (Fig.Â 2). However, mortality seems to be lowest"/>
 <result pre="in a systematic analysis involving 637 patients with MERS, the" exact="prevalence" post="of DM, HTN, CVD, and obesity was 50%, 50%,"/>
 <result pre="cohort of 1099 laboratory-confirmed COVID-19 patients (outpatient and inpatient), the" exact="prevalence" post="of patients having pre-existing HTN, DM, coronary artery disease"/>
 <result pre="1.4%, respectively.12 Among patients who were intubated or died, the" exact="prevalence" post="of these comorbidities increased to 36%, 27%, 9%, and"/>
 <result pre="CVDs report of the year 2018 from China reveals the" exact="prevalence" post="of HTN and DM to be 23.2% and 10.9%,"/>
 <result pre="23.2% and 10.9%, respectively, among the general population.15 Therefore, the" exact="prevalence" post="of HTN and diabetes in people infected with the"/>
 <result pre="higher cardiac troponin I levels in those with severe COVID-19" exact="infection" post="compared with those without (standardized mean difference: 25.6Â ng/L;"/>
 <result pre="imaging modalities such as cardiac PET to aid in the" exact="diagnosis" post="of COVID-19â€&quot;induced myocarditis. Until further data are available, one"/>
 <result pre="ventricular, was not specified. The possible mechanisms behind the higher" exact="prevalence" post="of arrhythmia among patients with COVID-19 include myocardial ischemia/injury,"/>
 <result pre="the thromboembolic disease should always be considered in the differential" exact="diagnosis" post="with a low threshold for using the appropriate diagnostic"/>
 <result pre="health-care system with patients with COVID-19 and fear of contracting" exact="infection" post="among patients. There is no apparent reason for a"/>
 <result pre="more in patients with prior CVD. Considerations for prevention and" exact="treatment" post="of cardiovascular complications India, as on 25th April 2020,"/>
 <result pre="mortality. Hence, appropriate protocols for rapid diagnosis, triaging, isolation, and" exact="treatment" post="of patients with COVID-19 with cardiovascular complications should be"/>
 <result pre="levels or natriuretic peptides in patients with COVID-19 unless the" exact="diagnosis" post="of acute MI or heart failure is suspected on"/>
 <result pre="severe disease and a more favorable clinical course towardÂ successful" exact="treatment" post="and discharge.20 Therefore, frequent and periodic estimation of cardiac"/>
 <result pre="induced by therapy with ACE-I or ARB would aggravate the" exact="infection" post="with SARS-CoV-2. However, the available data does not show"/>
 <result pre="online March 17collab: CDC COVID-19 Response TeamPreliminary estimates of the" exact="prevalence" post="of selected underlying health conditions among patients with coronavirus"/>
 <result pre="a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory" exact="infection" post="[published online ahead of print, 2020 Apr 8]Eur Heart"/>
 <result pre="in SARS coronavirus-induced lung injuryNat Med11200587587910.1038/nm126716007097 42BavishiC.MaddoxT.M.MesserliF.H.Coronavirus disease 2019 (COVID-19)" exact="infection" post="and renin angiotensin system BlockersJAMA Cardiol202010.1001/jamacardio.2020.1282Published online April 03"/>
</results>
